Search Results

Findings from Universidade do Estado do Amazonas Broaden Understanding of Leukemia [Plasminogen Activating Receptor Urokinase (U-par): Interaction And Implications in Tumor Microenvironment in Leukemias]

• Source: Obesity, Fitness & Wellness Week. November 9, 2024, p1680.

Record details

Recent Findings from Clayton Highlight Research in Drugs and Therapies (Obstructive Bilateral Renal Fungal Bezoars in an Extremely Premature Neonate Treated With Antifungals and Urokinase Irrigation: A Case Report and Review of the Literature)

• Source: Obesity, Fitness & Wellness Week. September 21, 2024, 666

Record details

Researchers from Chongqing Medical University Report Findings in Nanoclusters (Surface Confinement-induced Electrochemiluminescence Enhancement of Au Nanoclusters for Ultrasensitive Detection of a Soluble Urokinase-type Plasminogen Activator ...)

• Source: Obesity, Fitness & Wellness Week. July 20, 2024, 4242

Record details

Curasight AS Files Patent Application for Urokinase Plasminogen Activator Receptor Targeted Radiolabeled Peptide Conjugates.

• Source: Indian Patent News. 2024.

Record details

New Cancer Research Reported from Amravati (QSAR modelling to predict structural features of certain sulfonamide as Urokinase-type Plasminogen Activator inhibitors)

• Source: Obesity, Fitness & Wellness Week. June 15, 2024, 2517

Record details

Findings on Obesity, Fitness and Wellness Discussed by Investigators at Qingdao University (Nanomicrosphere Sustained-release Urokinase Systems With Antioxidant Properties for Deep Vein Thrombosis Therapy)

• Source: Obesity, Fitness & Wellness Week. April 6, 2024, 1704

Record details

Study Findings on Acute Kidney Injury Are Outlined in Reports from Zhengzhou University People's Hospital (Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury)

• Source: Obesity, Fitness & Wellness Week. December 14, 2024, 7235

Record details

College of Health and Medical Technology Researchers Have Published New Study Findings on Head and Neck Cancer [Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker of stage III-IV, grade C periodontitis through the ...]

• Source: Obesity, Fitness & Wellness Week. October 19, 2024, 1077

Record details

Heparin/urokinase: Lack of efficacy : 3 case reports.

Subjects: *UROKINASE; *HEPARIN; *HEART septum

• Source: Reactions Weekly. 7/27/2024, Vol. 2018 Issue 1, p224-224. 1p.

Record details

Anti-cancer drugs/Urokinase: Pyothorax, constrictive pericarditis and lack of efficacy.

Subjects: *ANTINEOPLASTIC agents; *UROKINASE; *PERICARDITIS

• Source: Reactions Weekly. Jul2024, Vol. 2015 Issue 1, p40-40. 1p.

Record details